HEALTH • WELLNESS • LONGEVITY • THERAPEUTICS
Explore the Platform
Who We Are
Building an integrated platform.
DSIpharma is developing a pharmaceutical, clinical and therapeutic platform focused on health, wellness, longevity and emerging therapeutic categories. The platform brings together formulation and development capabilities, physician-directed compounding, clinical expertise and advanced delivery technology—creating a foundation for pharmaceutical and patient-focused applications.
Why DSIpharma
Why DSIpharma?
30+ Years Formulation Expertise
Advanced Technology
Clinical Capabilities
Patient-Centered Design
Built for Expansion
Capabilities
One platform. Multiple capabilities.
Formulation Science
Formulation and development capabilities supporting pharmaceutical and therapeutic applications.
Compounding
In-house physician-prescribed compounding designed around patient-specific pharmaceutical needs.
Health & Longevity
A platform spanning health, wellness, longevity and emerging therapeutic categories.
Care Standards
Clinician-directed care, built with accountability.
DSIpharma brings clinical judgment, patient-specific care, and responsible operating practices together within one integrated platform.
Clinician-Prescribed Care
Care decisions are guided by licensed clinicians and tailored to individual patient needs.
Quality-Focused Operations
Operational systems and procedures support quality, documentation, and appropriate standards of care.
Patient-Specific Approach
The platform is designed around patient-focused care, clinical appropriateness, and individualized pathways.
Advanced DSI
Next-generation oral delivery technology.
Advanced DSI is a rapidly disintegrating, needle-free oral buccal delivery technology designed to support pharmaceutical and therapeutic applications. The technology provides a platform for patient-friendly administration and formulation opportunities across selected categories.
Rapid oral disintegration
Buccal delivery approach
Needle-free administration
Advanced DSI Technology
How the technology works.
Advanced DSI is designed around a direct, needle-free pathway from placement to peptide delivery.
01
Placement
Place the rapidly disintegrating tablet inside the cheek. It disintegrates in seconds with no chewing or swallowing needed.
02
Buccal Absorption
The tablet is absorbed by tiny blood vessels in the cheek, creating a direct route that bypasses the stomach and liver.
03
Systemic Delivery
Advanced DSI delivers peptides into systemic circulation for administration throughout the body.
Therapeutic Opportunity
Advanced DSI is designed to extend across therapeutic categories where oral, needle-free delivery can change how eligible therapies are administered — beginning with peptide, metabolic, wellness, and longevity medicine.
Metabolic & Weight Management
Cardiometabolic Care
Wellness & Longevity
Hormone & Longevity Medicine
Sexual Health
Sports Medicine & Recovery
Advancing peptide and therapeutic development through innovative formulation and oral-delivery technology, including GLP-1 and other emerging therapeutic applications. Advanced DSI Platform — 30+ years of formulation science. One next-generation platform.
Advanced DSI is a next-generation oral buccal delivery platform being developed to support eligible pharmaceutical and therapeutic applications. Its architecture is designed around needle-free administration, buccal delivery, and rapid tablet disintegration. The platform architecture is built to accommodate multiple eligible active ingredients, supported by in-house formulation development, analytical, and validation capabilities.
Advanced oral delivery · Buccal administration · Rapid disintegration · Peptide formulation · Flexible platform architecture · Formulation & development capabilities
Integrated Platform
From formulation to patient care.
01 Formulation
02 Compounding
03 Delivery
04 Clinical
05 Expansion
From Capability to Application
A connected pathway for peptide and therapeutic applications.
The same platform that develops formulations, prepares patient-specific medicines, and advances delivery technology creates a direct bridge to eligible peptide and therapeutic applications. Advanced DSI extends this continuum with needle-free oral buccal delivery—connecting formulation expertise to patient-centered care across emerging therapeutic categories.
The peptide platform below illustrates how this integrated capability can support emerging applications.
Peptide & Therapeutic Portfolio
Portfolio note: GLP-1 is presented as a metabolic application. All other peptide profiles shown represent emerging pipeline opportunities.
Metabolic Platform
GLP-1
Metabolic & therapeutic application
Peptide Platform
BPC-157
Emerging peptide application
Peptide Platform
TB-500
Emerging peptide application
Peptide Platform
KPV
Emerging peptide application
Peptide Platform
MOTS-c
Emerging peptide application